Literature DB >> 20345438

Contractile reserve assessed using dobutamine echocardiography predicts left ventricular reverse remodeling after cardiac resynchronization therapy: prospective validation in patients with left ventricular dyssynchrony.

Mario Sénéchal1, Patrizio Lancellotti, Julien Magne, Patrick Garceau, Jean Champagne, Louis Blier, Frank Molin, François Philippon, Moonen Marie, Gilles O'Hara, Michelle Dubois.   

Abstract

BACKGROUND: The presence of viable myocardium may predict response to cardiac resynchronization therapy (CRT). The aim of this study is to evaluate in patients with left ventricular (LV) dyssynchrony whether response to CRT is related to myocardial viability in the region of the pacing lead.
METHODS: Forty-nine consecutive patients with advanced heart failure, LV ejection fraction < 35%, QRS duration > 120 ms and intraventricular asynchronism > or = 50 ms were included. Dobutamine stress echocardiography was performed within the week before CRT implantation. Resting echocardiography was performed 6 months after CRT implantation. Viability in the region of LV pacing lead was defined as the presence of viability in two contiguous segments. Response to CRT was defined by evidence of reverse LV remodeling (> or =15% reduction in LV end-systolic volume).
RESULTS: Thirty-one patients (63%) were identified as responders at follow-up. The average of viable segments was 5.9 +/- 2 in responders and 3.2 +/- 3 in nonresponders (P = 0.0003). Viability in the region of the pacing lead had a sensitivity of 94%, a specificity of 67%, a positive predictive value of 83%, and a negative predictive value of 86% for the prediction of response to CRT.
CONCLUSIONS: In patients with LV dyssynchrony, reverse remodeling after CRT requires viability in the region of the pacing lead. This simple method using echocardiography dobutamine for the evaluation of local viability (i.e., viability in two contiguous segments) may be useful to the clinician in choosing the best LV lead positioning.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345438     DOI: 10.1111/j.1540-8175.2009.01106.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Current role of echocardiography in cardiac resynchronization therapy.

Authors:  Donato Mele; Matteo Bertini; Michele Malagù; Marianna Nardozza; Roberto Ferrari
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 2.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

3.  Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease.

Authors:  Eugenio Picano; Quirino Ciampi; Rodolfo Citro; Antonello D'Andrea; Maria Chiara Scali; Lauro Cortigiani; Iacopo Olivotto; Fabio Mori; Maurizio Galderisi; Marco Fabio Costantino; Lorenza Pratali; Giovanni Di Salvo; Eduardo Bossone; Francesco Ferrara; Luna Gargani; Fausto Rigo; Nicola Gaibazzi; Giuseppe Limongelli; Giuseppe Pacileo; Maria Grazia Andreassi; Bruno Pinamonti; Laura Massa; Marco A R Torres; Marcelo H Miglioranza; Clarissa Borguezan Daros; José Luis de Castro E Silva Pretto; Branko Beleslin; Ana Djordjevic-Dikic; Albert Varga; Attila Palinkas; Gergely Agoston; Dario Gregori; Paolo Trambaiolo; Sergio Severino; Ayana Arystan; Marco Paterni; Clara Carpeggiani; Paolo Colonna
Journal:  Cardiovasc Ultrasound       Date:  2017-01-18       Impact factor: 2.062

Review 4.  Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.

Authors:  Quirino Ciampi; Clara Carpeggiani; Claudio Michelassi; Bruno Villari; Eugenio Picano
Journal:  BMC Cardiovasc Disord       Date:  2017-08-16       Impact factor: 2.298

5.  Clinical implications of left atrial reverse remodelling after cardiac resynchronization therapy.

Authors:  Jan Stassen; Xavier Galloo; Surenjav Chimed; Kensuke Hirasawa; Nina Ajmone Marsan; Victoria Delgado; Pieter van der Bijl; Jeroen J Bax
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-06-01       Impact factor: 9.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.